236 related articles for article (PubMed ID: 32519226)
1. The treatment efficacy of adding prokinetics to PPIs for gastroesophageal reflux disease: a meta-analysis.
Xi L; Zhu J; Zhang H; Muktiali M; Li Y; Wu A
Esophagus; 2021 Jan; 18(1):144-151. PubMed ID: 32519226
[TBL] [Abstract][Full Text] [Related]
2. Addition of prokinetics to PPI therapy in gastroesophageal reflux disease: a meta-analysis.
Ren LH; Chen WX; Qian LJ; Li S; Gu M; Shi RH
World J Gastroenterol; 2014 Mar; 20(9):2412-9. PubMed ID: 24605040
[TBL] [Abstract][Full Text] [Related]
3. Short-term treatment with proton pump inhibitors, H2-receptor antagonists and prokinetics for gastro-oesophageal reflux disease-like symptoms and endoscopy negative reflux disease.
van Pinxteren B; Sigterman KE; Bonis P; Lau J; Numans ME
Cochrane Database Syst Rev; 2010 Nov; (11):CD002095. PubMed ID: 21069670
[TBL] [Abstract][Full Text] [Related]
4. Proton pump inhibitors for functional dyspepsia.
Pinto-Sanchez MI; Yuan Y; Hassan A; Bercik P; Moayyedi P
Cochrane Database Syst Rev; 2017 Nov; 11(11):CD011194. PubMed ID: 29161458
[TBL] [Abstract][Full Text] [Related]
5. Short-term treatment with proton pump inhibitors, H2-receptor antagonists and prokinetics for gastro-oesophageal reflux disease-like symptoms and endoscopy negative reflux disease.
van Pinxteren B; Numans ME; Bonis PA; Lau J
Cochrane Database Syst Rev; 2006 Jul; (3):CD002095. PubMed ID: 16855986
[TBL] [Abstract][Full Text] [Related]
6. Short-term treatment with proton pump inhibitors, H2-receptor antagonists and prokinetics for gastro-oesophageal reflux disease-like symptoms and endoscopy negative reflux disease.
van Pinxteren B; Numans ME; Bonis PA; Lau J
Cochrane Database Syst Rev; 2004 Oct; (4):CD002095. PubMed ID: 15495027
[TBL] [Abstract][Full Text] [Related]
7. Short-term treatment with proton pump inhibitors, H2-receptor antagonists and prokinetics for gastro-oesophageal reflux disease-like symptoms and endoscopy negative reflux disease.
Sigterman KE; van Pinxteren B; Bonis PA; Lau J; Numans ME
Cochrane Database Syst Rev; 2013 May; 2013(5):CD002095. PubMed ID: 23728637
[TBL] [Abstract][Full Text] [Related]
8. Short-term treatment with proton pump inhibitors, H2-receptor antagonists and prokinetics for gastro-oesophageal reflux disease-like symptoms and endoscopy negative reflux disease.
van Pinxteren B; Numans ME; Bonis PA; Lau J
Cochrane Database Syst Rev; 2001; (4):CD002095. PubMed ID: 11687139
[TBL] [Abstract][Full Text] [Related]
9. Short-term treatment with proton pump inhibitors, H2-receptor antagonists and prokinetics for gastro-oesophageal reflux disease-like symptoms and endoscopy negative reflux disease.
van Pinxteren B; Numans ME; Bonis PA; Lau J
Cochrane Database Syst Rev; 2000; (2):CD002095. PubMed ID: 10796857
[TBL] [Abstract][Full Text] [Related]
10. Proton pump inhibitors for functional dyspepsia.
Pinto-Sanchez MI; Yuan Y; Bercik P; Moayyedi P
Cochrane Database Syst Rev; 2017 Mar; 3(3):CD011194. PubMed ID: 28271513
[TBL] [Abstract][Full Text] [Related]
11. A Systematic Review and Meta-analysis of Randomized Control Trials: Combination Treatment With Proton Pump Inhibitor Plus Prokinetic for Gastroesophageal Reflux Disease.
Jung DH; Huh CW; Lee SK; Park JC; Shin SK; Lee YC
J Neurogastroenterol Motil; 2021 Apr; 27(2):165-175. PubMed ID: 33795539
[TBL] [Abstract][Full Text] [Related]
12. Efficacy of the addition of prokinetics for proton pump inhibitor (PPI) resistant non-erosive reflux disease (NERD) patients: significance of frequency scale for the symptom of GERD (FSSG) on decision of treatment strategy.
Miyamoto M; Manabe N; Haruma K
Intern Med; 2010; 49(15):1469-76. PubMed ID: 20686276
[TBL] [Abstract][Full Text] [Related]
13. Frequency scale for symptoms of gastroesophageal reflux disease predicts the need for addition of prokinetics to proton pump inhibitor therapy.
Miyamoto M; Haruma K; Takeuchi K; Kuwabara M
J Gastroenterol Hepatol; 2008 May; 23(5):746-51. PubMed ID: 18028348
[TBL] [Abstract][Full Text] [Related]
14. Alginate therapy is effective treatment for gastroesophageal reflux disease symptoms: a systematic review and meta-analysis.
Leiman DA; Riff BP; Morgan S; Metz DC; Falk GW; French B; Umscheid CA; Lewis JD
Dis Esophagus; 2017 Feb; 30(2):1-8. PubMed ID: 27671545
[TBL] [Abstract][Full Text] [Related]
15. WITHDRAWN: Medical treatments in the short term management of reflux oesophagitis.
Moayyedi P; Santana J; Khan M; Preston C; Donnellan C
Cochrane Database Syst Rev; 2011 Feb; (2):CD003244. PubMed ID: 21328259
[TBL] [Abstract][Full Text] [Related]
16. Medical treatments in the short term management of reflux oesophagitis.
Khan M; Santana J; Donnellan C; Preston C; Moayyedi P
Cochrane Database Syst Rev; 2007 Apr; (2):CD003244. PubMed ID: 17443524
[TBL] [Abstract][Full Text] [Related]
17. Efficacy of mosapride plus proton pump inhibitors for treatment of gastroesophageal reflux disease: a systematic review.
Liu Q; Feng CC; Wang EM; Yan XJ; Chen SL
World J Gastroenterol; 2013 Dec; 19(47):9111-8. PubMed ID: 24379638
[TBL] [Abstract][Full Text] [Related]
18. Gastroesophageal reflux disease: exaggerations, evidence and clinical practice.
Ferreira CT; Carvalho Ed; Sdepanian VL; Morais MB; Vieira MC; Silva LR
J Pediatr (Rio J); 2014; 90(2):105-18. PubMed ID: 24184302
[TBL] [Abstract][Full Text] [Related]
19. HISTORICAL PERSPECTIVE OF GASTROESOPHAGEAL REFLUX DISEASE CLINICAL TREATMENT.
Zaterka S; Marion SB; Roveda F; Perrotti MA; Chinzon D
Arq Gastroenterol; 2019 Aug; 56(2):202-208. PubMed ID: 31460587
[TBL] [Abstract][Full Text] [Related]
20. Short-term treatment of gastroesophageal reflux disease.
van Pinxteren B; Numans ME; Lau J; de Wit NJ; Hungin AP; Bonis PA
J Gen Intern Med; 2003 Sep; 18(9):755-63. PubMed ID: 12950485
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]